top of page

News


Search


Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases...
Renovion
Apr 7, 20222 min read


A breathe-easier breakthrough
Renovion, a UNC-affiliated startup, advances a breakthrough therapy to restore lung health and quality of life in patients with diseases...
Renovion
Nov 18, 20216 min read


Exploristics signs collaboration agreement with Renovion, using the cloud-based simulation platform
Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform...
Renovion
Nov 8, 20213 min read


Renovion and the COPD Foundation Launch COPD and Bronchiectasis Development Partnership
Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for...
Renovion
Sep 21, 20213 min read


Renovion Announces Addition of Rich Mattingly to Board of Directors
Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced the...
Renovion
Sep 4, 20202 min read


Publication of Research Demonstrating the Impact of ARINA-1 on Mucus Transport in Cystic Fibrosis
Renovion, Inc., a biopharmaceutical company on a mission to transform the lives of patients with chronic lung diseases characterized by...
Renovion
Jul 9, 20202 min read

bottom of page